Inhibitors of signal transduction: The alkylphosphocholines

被引：0

作者：

Hilgard, F ^{[1
]}

Klenner, T ^{[1
]}

Engel, J ^{[1
]}

机构：

[1] ASTA Med AG, Expt Canc Res, D-60001 Frankfurt, Germany

来源：

DRUG NEWS & PERSPECTIVES | 1999年 / 12卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The experimental antitumor activity of the alkylphosphocholines, a new class of signal transduction inhibitors, has been demonstrated repeatedly. The alkylphosphocholines have inhibitory activities on protein kinase C (PKC) and phospholipase C. The PKC pathway of signal transduction may be involved in cellular differentiation and in the induction of apoptosis. Moreover, PKC inhibition by miltefosine may affect tumor invasion and metastasis formation. Miltefosine may also interfere with immunological mechanisms. Finally, in addition to its antitumor activity, miltefosine also exerts substantial effects on a number of Leishmania strains. In brief, miltefosine and other alkylphosphocholines interact with signal transduction components of cellular functions such as differentiation, growth control, migration, tumor promotion and cell death. Due to these activities, this new class of pharmacophores has a great potential in the treatment of cancer and certain parasitic diseases. (C) 1999 Prous Science. All rights reserved.

引用

页码：69 / 72

页数：4

共 50 条

[31] Signal Transduction Inhibitors and Antiangiogenic Therapies for Malignant Glioma [J].

Mellinghoff, Ingo K. ;

Lassman, Andrew B. ;

Wen, Patrick Y. .

GLIA, 2011, 59 (08) :1205-1212

[32] Signal transduction inhibitors in the management of hematologic malignancies. [J].

Claxton, David F. .

ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2007, 37 (02) :196-196

[33] Inhibitors of eukaryotic signal transduction from fungi. [J].

Erkel, G ;

Engel, B ;

Gehrt, A ;

Anke, T .

MOLECULAR BIOLOGY OF THE CELL, 1996, 7 :2999-2999

[34] Oncogene signal transduction inhibitors from medicinal plants [J].

Chang, CJ ;

Ashendel, CL ;

Geahlen, RL ;

McLaughlin, JL ;

Waters, DJ .

IN VIVO, 1996, 10 (02) :185-190

[35] Signal transduction therapy with rationally designed kinase inhibitors [J].

Keri, Gyoergy ;

Orfi, Laszlo ;

Eros, Daniel ;

Hegymegi-Barakonyi, Balint ;

Szantai-Kis, Csaba ;

Horvath, Zoltan ;

Waczek, Frigyes ;

Marosfalvi, Jeno ;

Szabadkai, Istvan ;

Pato, Janos ;

Greff, Zoltan ;

Hafenbradl, Doris ;

Daub, Henrik ;

Mueller, Gerhard ;

Klebl, Bert ;

Ullrich, Axel .

CURRENT SIGNAL TRANSDUCTION THERAPY, 2006, 1 (01) :67-95

[36] DOWN-REGULATION OF ONCOGENES BY INHIBITORS OF SIGNAL TRANSDUCTION [J].

Olah, Edith .

ANTICANCER RESEARCH, 2004, 24 (5D) :3585-3585

[37] Signal-transduction inhibitors in renal cell carcinoma [J].

Vogelzang, Nicholas J. ;

Sternberg, Cora N. .

BJU INTERNATIONAL, 2007, 99 (05) :1289-1295

[38] Inhibitors targeting two-component signal transduction [J].

Watanabe, Takafumi ;

Okada, Ario ;

Gotoh, Yasuhiro ;

Utsumi, Ryutaro .

BACTERIAL SIGNAL TRANSDUCTION: NETWORKS AND DRUG TARGETS, 2008, 631 :229-236

[39] New therapeutics and breast cancer: signal transduction inhibitors [J].

Campone, M. .

ONCOLOGIE, 2007, 9 :S33-S40

[40] Induction of cellular differentiation and apoptosis by signal transduction inhibitors [J].

Umezawa, K .

ADVANCES IN ENZYME REGULATION, VOL 37, 1997, 37 :393-401

← 1 2 3 4 5 →